diabetes

Fitterfly (a division of PB Health) Secures Patent for PGR Technology to Drive Better Diabetes Outcomes

In an industry first, Fitterfly by PB Health has secured a Govt. of India patent for its Personalised Glycemic Response…

2 weeks ago

Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund

COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes‑tech company Hedia is implementing a leadership change effective 1 December 2025,…

2 weeks ago

Aeroflow Health Named to The Healthcare Technology Report’s Top 50 Healthcare Technology Companies of 2025

ASHEVILLE, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health, a healthcare company pioneering technology for medical products and services,…

4 weeks ago

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…

1 month ago

Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza

Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together…

2 months ago

Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD

VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD…

2 months ago

Sandstone Easydrip Plus Pen Needles Debut in Turkey — PatentProtected Hexagonal Hub for Comfort and Control

Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading…

2 months ago

Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas

Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…

4 months ago

Immutheras Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz,…

6 months ago

ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment

LONDON, June 28, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research…

6 months ago